Browse by People

Collapse authors list.
Neoptolemos, JP, Palmer, DH ORCID: 0000-0002-7147-5703, Ghaneh, P, Psarelli, EE ORCID: 0000-0002-3102-0288, Valle, JW, Halloran, CM ORCID: 0000-0002-5471-4178, Faluyi, O, O'Reilly, DA, Cunningham, D, Wadsley, J et al (show 24 more authors) , Darby, S, Meyer, T, Gillmore, R, Anthoney, A, Lind, P, Glimelius, B, Falk, S, Izbicki, JR, Middleton, GW, Cummins, S, Ross, PJ, Wasan, H, McDonald, A, Crosby, T, Ma, YT, Patel, K, Sherriff, D, Soomal, R, Borg, D, Sothi, S, Hammel, P, Hackert, T, Jackson, R and Büchler, MW (2017) Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet (London, England), 389 (10073). pp. 1011-1024.

Collapse authors list.
Neoptolemos, JP, Palmer, DH ORCID: 0000-0002-7147-5703, Ghaneh, P, Psarelli, EE ORCID: 0000-0002-3102-0288, Valle, JW, Halloran, CM ORCID: 0000-0002-5471-4178, Faluyi, O, O'Reilly, DA, Cunningham, D, Wadsley, J et al (show 24 more authors) , Darby, S, Meyer, T, Gillmore, R, Anthoney, A, Lind, P, Glimelius, B, Falk, S, Izbicki, JR, Middleton, GW, Cummins, S, Ross, PJ, Wasan, H, McDonald, A, Crosby, T, Ma, YT, Patel, K, Sherriff, D, Soomal, R, Borg, D, Sothi, S, Hammel, P, Hackert, T, Jackson, R and Büchler, MW (2017) Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet (London, England), 389 (10073). 1011 - 1024.

Collapse authors list.
Elander, NO, Aughton, K ORCID: 0000-0002-5184-5789, Ghaneh, P, Neoptolemos, JP, Palmer, DH ORCID: 0000-0002-7147-5703, Cox, TF, Campbell, F, Costello-Goldring, E ORCID: 0000-0002-0104-8992, Halloran, CM ORCID: 0000-0002-5471-4178, Mackey, JR et al (show 16 more authors) , Scarfe, AG, Valle, JW, McDonald, AC, Carter, R, Tebbutt, MC, Goldsein, D, Shannon, J, Dervenis, C, Glimelius, B, Deakin, M, Charnley, RM, Anthoney, A, Lerch, MM, Mayerle, J, Buchler, MW and Greenhalf, W (2018) Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predict survival in pancreatic cancer. British Journal of Cancer, 118 (7). pp. 947-954.

Collapse authors list.
Elander, NO, Aughton, K ORCID: 0000-0002-5184-5789, Ghaneh, P, Neoptolemos, JP, Palmer, DH ORCID: 0000-0002-7147-5703, Cox, TF, Campbell, F, Costello, E, Halloran, CM ORCID: 0000-0002-5471-4178, Mackey, JR et al (show 18 more authors) , Scarfe, AG, Valle, JW, McDonald, AC, Carter, R, Tebbutt, NC, Goldstein, D, Shannon, J, Dervenis, C, Glimelius, B, Deakin, M, Charnley, RM, Anthoney, A, Lerch, MM, Mayerle, J, Olah, A, Buchler, MW, Greenhalf, W and Canc, European Study Grp Pancreatic (2018) Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy. British Journal of Cancer, 118 (8). pp. 1084-1088.